logo-alt.png
Global Aptamers Market accounted for US$ 205.40 million in 2020 and is estimated to be US$ 985.44 million by 2030 and is anticipated to register a CAGR of 16.90% - By PMI
February 01, 2022 09:57 ET | PMI
Covina, Feb. 01, 2022 (GLOBE NEWSWIRE) --   The report "Global Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application...
Inc. BIB Social Toolkit Image_2
FourKites Named to Inc.’s 2021 Best in Business List in the Logistics & Transportation Category
December 08, 2021 07:30 ET | FourKites
CHICAGO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- FourKites®, the world’s leading real-time supply chain visibility platform, has been named to the Inc. 2021 Best in Business list in the Logistics and...
logo.png
For the 2nd Consecutive Year, Liquipel Appears on the Inc. 5000, With Revenue Growth of 207 percent!
September 23, 2021 09:00 ET | Liquipel Assurance LLC
IRVINE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Inc. magazine today revealed that Liquipel is on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private...
DISQO_logo_1200x628-01.png
DISQO Ranks in Top 1000 on the 2020 Inc. 5000
August 18, 2020 11:10 ET | Disqo
Consumer insights platform founded on first-party audience records three-year growth of 486 percent. LOS ANGELES, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Consumer insights platform DISQO, known for...
BDev_Logo_Originales_RGB_Azul_Vertical.jpg
BairesDev selected in Inc. 5000’s List of California’s Fastest-Growing Companies
March 10, 2020 15:00 ET | BairesDev
CAMPBELL, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- BairesDev, a software outsourcing company founded in 2009, was recognized on the first edition of California’s Inc. 5000 list, the state-based...
22157.jpg
Global Cancer Immunotherapy Market Outlook to 2023: Includes Coverage of the Future Impact of CAR-T Therapies
December 16, 2019 12:58 ET | Research and Markets
Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Global Cancer Immunotherapy Market Analysis & Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. Within the...
HP Elite Slice G2 With Zoom Rooms
Zoom and HP Collaborate to Create Modern Workspaces for Today’s Workforce
March 19, 2019 10:00 ET | Zoom Video Communications
SAN JOSE, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Zoom Video Communications, Inc. today announced a partnership with HP Inc. to meet the collaboration needs of today’s teams for video-first...
imv-logo.jpg
IMV Inc. Presents Updated Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ESMO Immuno-Oncology Congress
December 13, 2018 04:05 ET | IMV Inc.
73% of tumor regressions and 80% of clinical responses were observed in a subpopulation defined by a clinical biomarker based on Baseline Tumor Burden All durable clinical responses continued beyond...
imv-logo.jpg
IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018
December 10, 2018 07:05 ET | IMV Inc.
DARTMOUTH, Nova Scotia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that investigators will present data via a...
imv-logo.jpg
IMV Welcomes Marc Jasmin as Senior Director, Investor Relations and Communications
December 05, 2018 07:05 ET | IMV Inc.
DARTMOUTH, Nova Scotia, Dec. 05, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Marc Jasmin has joined the Company in...